Securities code: By-Health Co.Ltd(300146) securities abbreviation: By-Health Co.Ltd(300146) Announcement No.: 2022006
By-Health Co.Ltd(300146)
Summary of annual report 2021
1、 Important tips
The summary of the company’s operating results and future financial results for this year is the full text of the report
For the exhibition planning, investors shall carefully read the full text of the annual report in the media designated by the CSRC.
All directors of the company personally attended the meeting of the board of directors to consider this annual report.
The audit opinion of Huaxing Certified Public Accountants (special general partnership) on the company’s financial report this year is: Standard non guaranteed
Leave a comment.
The accounting firm of the company this year is Huaxing accounting firm (special general partnership), and there is no change.
Tips on non-standard audit opinions
□ applicable √ not applicable
The company was not profitable at the time of listing and is not profitable at present
□ applicable √ not applicable
The profit distribution plan of ordinary shares or the plan of converting accumulation fund into share capital in the reporting period considered by the board of directors
√ applicable □ not applicable
The company’s profit distribution plan for common shares reviewed and approved by the board of directors is: take 1700308763 as the base, to the whole company
The shareholders of the consortium will distribute cash dividends of 7.00 yuan (including tax) for every 10 shares and 0 bonus shares (including tax) to all shares with capital reserve
East China shares will be increased by 0 shares for every 10 shares.
Profit distribution plan for preferred shares in the reporting period adopted by the board of directors
□ applicable √ not applicable
2、 Basic information of the company
1. Company profile
Stock abbreviation By-Health Co.Ltd(300146) stock code By-Health Co.Ltd(300146)
Shenzhen Stock Exchange
Contact person and contact information secretary of the board of directors securities affairs representative
Name: Tang Jinyin Guanyan Village
Office address: No. 99, science Avenue, Science City, Huangpu District, Guangzhou Branch, No. 3, Kehui Jingu 3rd Street, No. 99, science Avenue, Science City, Huangpu District, Guangzhou
Fax: 0202895790102028957901
Tel: 0202895666602028956666
E-mail tcbj@by -health. com. tcbj@by -health. com.
2. Introduction to main business or products during the reporting period
(1) Industry of the company
The company is in the industry of dietary nutritional supplements. Dietary nutritional supplement (VDS) is a food with vitamins, minerals, animal and plant extracts as the main raw materials, which can improve the health level of the body and reduce the risk of disease by supplementing essential nutrients and bioactive substances, and does not cause any acute, subacute or chronic harm to the human body. As the development history of VDS in China is still short, and the consumption awareness and habits of residents have not been fully established, VDS has a large growth space in terms of penetration, consumption stickiness and per capita consumption amount compared with developed countries such as the United States and Japan, and the industry prospect and subdivided fields can be expected to grow in the future. According to Euromonitor data, the total scale of China’s vitamin and dietary supplement industry in 2021 was 189.2 billion yuan, an increase of 6.60% over the previous year.
The aging population and consumption upgrading create space for the development of the industry. On the one hand, from the perspective of population structure, China has entered an aging society. The deepening of population aging has brought huge market space to VDS industry. On the other hand, with the upgrading of consumption structure, health, nutrition, personality and convenience have become the focus of public attention, and the functional demands have been continuously subdivided and specialized. In addition, VDS dosage forms are more diversified and develop in the direction of food, which promotes the rapid growth of VDS sub fields and creates broad space for the development of the industry.
The rise of national health awareness lays the cornerstone for the development of the industry. With the improvement of residents’ income level and quality of life, consumers’ demands for healthy life are becoming more and more prominent, laying a good foundation for the development of the whole nutrition and health industry. The sudden covid-19 epidemic in 2020 has profoundly changed the health concept of Chinese people and accelerated the growth of market demand for nutrition and health-related products in the post epidemic era.
Stricter supervision escorts the development of the industry. In April 2020, the State Administration of market supervision and other seven ministries and commissions jointly issued the action plan for the clean-up and rectification of the health food industry (20202021), which pointed out that “vigorously rectify the fraud and false publicity of health food” “Strive to effectively purify the health food market by the end of 2021 and continuously improve the people’s sense of access, happiness and security to the health food consumption market”. On January 17, 2022, the State Administration of Market Supervision issued the public solicitation of the announcement on the release of non nutrient supplements (2022 version) and supporting documents of the catalogue of health functions allowed to be claimed by health food (Exposure Draft), the interpretation of health food function claims (2022 version) (exposure draft), and other documents, It has formulated a set of clear concept claim system and compliance standards for health food, which is conducive to market norms and consumer education.
With the improvement of laws and regulations and the increasingly standardized supervision of the whole industry, it will help to solve the chaotic situation of industry supervision, accelerate the centralization of the industry and escort the long-term and healthy development of the industry.
(2) Main business of the company
By-Health Co.Ltd(300146) implements the strategy of “all the way to C” to create value for users’ health. In 2002, By-Health Co.Ltd(300146) systematically introduced VDS into China’s non direct sales field, established a comprehensive scientific system of dietary nutritional supplements based on modern nutrition science, and formed a product line layout of full category, full population and full coverage through independent / cooperative research and acquisition. Industry owned by the company
The professional “Transparent Factory” is one of the world’s leading production bases of dietary and nutritional supplements with strict quality control
We conduct a number of high-standard testing projects to create reassuring high-quality products with strict requirements. The company’s positioning is not for customers,
Instead, it produces global high-quality nutrients for family and friends.
As a leading enterprise in the global VDS industry, over the years, the company has continuously built and improved its channel power, product power and brand
And service capabilities, and constantly maintain and expand the company’s market leading edge. Euromonitor data show that in 2021
The company’s market share in China’s vitamin and dietary supplement industry is 10.3%, ranking first.
Backed by the industry dividend with large growth space of VDS in China, the company adheres to the implementation of scientific nutrition strategy and is committed to R & D and innovation
And new nutritional ecological construction to better meet the health needs of the people. Join hands with global cutting-edge scientific research forces and cooperate with Dutch countries
Scientific research institutions such as the Academy of Sciences and the Shanghai Institute of nutrition and health of the Chinese Academy of Sciences continue to carry out forward-looking research on nutrition science
Many results have been achieved. At the same time, scientific nutrition is arranged to study the improvement of a variety of chronic diseases, and is committed to improving human health
Situation. The new ecology of nutrition and health in the post epidemic era cannot be separated from the connection and drive of science and technology. The company will closely focus on consumer health,
Continue to strengthen scientific research investment and talent construction, become a new nutritional ecological builder driven by science and technology, and lead the upgrading and development of the industry.
3. Main accounting data and financial indicators
(1) Main accounting data and financial indicators in recent three years
Does the company need to retroactively adjust or restate the accounting data of previous years
□ yes √ no
Unit: Yuan
Year end 2021 year end 2020 year end increase or decrease over the previous year year end 2019 year end
Total assets 1296592674150964026259541 34.50% 833071028066
Net assets attributable to shareholders of listed companies 1049394855208693355 Suzhou Cheersson Precision Metal Forming Co.Ltd(002976) 51.35% 599217396190
20212020 year-on-year increase or decrease 2019
Operating income 743127812959609490094370 21.93% 526179943925
Net profit attributable to shareholders of listed companies 175397927319152425124595 15.07% – 35588961546
Deduction attributable to shareholders of listed companies
Net profit of recurring profit and loss 154026335868114442596525 34.59% – 43051892011
Net cash flow from operating activities 181897802797156636437394 16.13% 153652010303
Basic earnings per share (yuan / share) 1.06 0.96 10.42% – 0.24
Diluted earnings per share (yuan / share) 1.05 0.96 9.38% – 0.24
The weighted average return on net assets was 19.34%, 23.97%, down 4.63 percentage points – 6.50%
(2) Main accounting data by quarter
Unit: Yuan
First quarter second quarter third quarter fourth quarter
Operating income 222250094510197535508531183066313813140275896105
Net profit attributable to shareholders of listed companies 8163012154855483841397291729153989111048976
Deduction attributable to shareholders of listed companies
Net profit of recurring profit and loss: 76315011776
